MusclePharm Corporation Gross Margin
- Gross margin · 12 months: Value 6.38%; Formula and calculation Gross profit / revenue. Period ending 2022-03-31..
Gross margin
Overview →Financial period ending 2022-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 6.38% | Gross profit / revenue. Period ending 2022-03-31. $3.19M ÷ $50.02M × 100 ≈ 6.38% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 3.19M USD | Gross Profit |
| Revenue | 50.02M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 46.83M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2022-03-31 | $3.19M | $50.02M | $46.83M | 6.38% |
| 2021-12-31 | $5.37M | $50.04M | $44.67M | 10.73% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | $18.49M | $61.33M | $42.84M | 30.15% |
| 2020-12-31 | $19.61M | $64.44M | $44.83M | 30.43% |
| 2020-09-30 | $17.32M | $66.73M | $49.41M | 25.96% |
| 2020-06-30 | $13.84M | $71.82M | $57.98M | 19.26% |
| 2020-03-31 | $10.58M | $77.12M | $66.55M | 13.71% |
| 2019-12-31 | (m) | $79.67M | (m) | (m) |
| 2019-09-30 | (m) | $82.41M | (m) | (m) |
| 2019-06-30 | (m) | $83.17M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $66.41M | (m) |
| 2018-12-31 | $18.39M | $88.11M | $69.72M | 20.88% |
| 2018-09-30 | $16.10M | (m) | $68.83M | (m) |
| 2018-06-30 | $18.59M | (m) | $68.81M | (m) |
| 2018-03-31 | (m) | $102.69M | (m) | (m) |
| 2017-12-31 | (m) | $102.16M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | $35.73M | $115.60M | $79.87M | 30.91% |
| 2016-12-31 | $44.47M | $132.50M | $88.03M | 33.56% |
| 2016-09-30 | $50.67M | $147.55M | $96.88M | 34.34% |
| 2016-06-30 | $50.95M | $150.84M | $99.89M | 33.78% |
| 2016-03-31 | $57.76M | $168.45M | $110.69M | 34.29% |
| 2015-12-31 | $56.93M | $166.86M | $109.93M | 34.12% |
| 2015-09-30 | $49.89M | $158.45M | $108.56M | 31.48% |
| 2015-06-30 | $54.37M | $172.24M | $117.86M | 31.57% |
| 2015-03-31 | $52.52M | $168.50M | $115.98M | 31.17% |
| 2014-12-31 | $56.01M | $177.39M | $121.38M | 31.57% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $33.19M | $110.88M | $77.69M | 29.94% |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | $14.33M | $67.06M | $52.73M | 21.37% |
| 2012-09-30 | $10.55M | $56.90M | $46.35M | 18.55% |
| 2012-06-30 | $7.00M | $42.77M | $35.77M | 16.37% |
| 2012-03-31 | $5.40M | $30.74M | $25.34M | 17.57% |
| 2011-12-31 | $2.37M | $17.21M | $14.85M | 13.75% |
| 2011-09-30 | $1.42M | $10.94M | $9.53M | 12.93% |
| 2011-06-30 | $1.38M | $7.91M | $6.53M | 17.47% |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $398.41K | $3.20M | $2.80M | 12.44% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $94.94K | $1.02M | $922.97K | 9.33% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.